SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
___________________
Date of Report (Date of earliest event reported) November 7, 2000
BICO, INC.
(Exact name of registrant as specified in its charter)
Pennsylvania 0-10822 25-1229323
(State of other jurisdiction Commission File Number) (IRS Employer
of incorporation) dentification No.)
2275 Swallow Hill Road, Bldg. 2500, Pittsburgh, Pennsylvania 15220
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (412) 429-0673
_________________________________________________________
(Former name or former address,
if changes since last report.)
Item 1. Change in Control of Registrant.
Not applicable.
Item 2. Acquisition or Disposition of Assets.
Not applicable.
Item 3. Bankruptcy or Receivership.
Not applicable.
Item 4. Changes in Registrant's Certifying Accountant
Not applicable.
Item 5. Other Events.
BICO, Inc. subsidiary, ViaCirQ, Inc. a leading
developer and marketer of extracorporeal
hyperthermia medical devices, announced today that
it has entered into a contract to provide Zale
Lipshy University Hospital at Southwestern Medical
Center with the ThermoChem-HT System and
disposables for all intraperitoneal hyperthermia
procedures. Terms of the contract are not
disclosed at this time.
Item 6. Resignation of Registrant's Directors.
Not Applicable
Item 7. Financial Statement, Pro Forma Financial Information and Exhibits.
(a) Financial Statements and Businesses Acquired - Not Applicable.
(b) Pro Forma Financial Information - Not Applicable.
(c) Exhibits - Press Release.
SIGNATURES
Pursuant to the requirement of the Securities Exchange Act of 1934, the
Registrant has duly caused this Report to be signed on its behalf by the
undersigned hereunto duly authorized.
BICO, INC.
by /s/ Fred E. Cooper
Fred E. Cooper, CEO
DATED: November 7, 2000
BICO SUBSIDIARY, VIACIRQ, RECEIVES CONTRACT FROM ZALE LIPSHY
UNIVERSITY HOSPITAL AT SOUTHWESTERN MEDICAL CENTER
Pittsburgh, PA - November 7, 2000 - BICO, Inc.
(OTCBB:BIKO) subsidiary, ViaCirQ, Inc., a leading developer
and marketer of extracorporeal hyperthermia medical devices,
announced today that it has entered into a contract to
provide Zale Lipshy University Hospital at Southwestern
Medical Center with the ThermoChem-HT System and disposables
for all intraperitoneal hyperthermia procedures. Terms of
the contract are not disclosed at this time.
Zale Lipshy University Hospital serves as the private
adult referral teaching hospital for the University of Texas
Southwestern Medical Center at Dallas.
Intraperitoneal hyperthermia is used as an adjunctive
therapy with surgery and chemotherapy to treat patients with
peritoneal carcinomatosis (advanced cancer of the abdomen).
This treatment is available at Zale Lipshy for qualified
patients with this advanced cancer.
"We are pleased to be working with such a prestigious
hospital as Zale Lipshy University Hospital as we continue
to execute the first program of our platform to bring
intraperitoneal hyperthermia utilizing the ThermoChem-HT
System to all cancer centers in the United States," said
Glenn Keeling, Chief Executive Officer of ViaCirQ.
ViaCirQ received FDA clearance to market the ThermoChem-
HT System to raise the core temperature of the abdominal
cavity to the desired targeted temperature in the 41C
(105.8F) to 42C (107.6F) range by continuously lavaging the
abdomen with circulating sterile solution. Studies have
shown that heating of the abdominal cavity can make the area
more receptive to adjunctive therapies physicians might
choose, such as chemotherapy.
BICO, Inc. has its corporate offices in Pittsburgh, PA
and is involved in the development and manufacture of
biomedical devices and environmental solutions. BICO's
subsidiary, ViaCirQ, Inc., also located in Pittsburgh, PA,
holds exclusive worldwide marketing and manufacturing rights
to the ThermoChem-HT System and related disposables for
regional hyperthermia and the ThermoChem System and related
disposables for whole body hyperthermia.
FOR FURTHER INFORMATION, CONTACT:
Investors Media
Diane McQuaide Susan Taylor
1.412.429.0673 phone 1.412.429.0673 phone
1.412.279.9690 fax 1.412.279.5041 fax
INVESTOR RELATIONS NEWSLINE NUMBER: 1.800.357.6204
WEBSITE: www.bico.com
